Home › Asset managers › Guggenheim › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,550 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|---|
| American Well Corporation | June 16, 2026 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders: Dr. Ido Schoenberg | Director Elections | Board | WITHHOLD | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: Amish Gupta | Director Elections | Board | AGAINST | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: David W. Johnson | Director Elections | Board | AGAINST | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: Frederick J. Kleisner | Director Elections | Board | AGAINST | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: Monty J. Bennett | Director Elections | Board | AGAINST | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: Sheri L. Pantermuehl | Director Elections | Board | AGAINST | 1 | |
| Ashford Hospitality Trust, Inc. | May 12, 2026 | Election of Directors: Stephen Zsigray | Director Elections | Board | AGAINST | 1 | |
| Aterian, Inc. | August 12, 2025 | To elect Arturo Rodriguez as a Class III director to serve until our 2028 Annual Meeting of Stockholders: Arturo Rodriguez | Director Elections | Board | AGAINST | 1 | |
| Avalo Therapeutics, Inc. | June 2, 2026 | To approve the Avalo Therapeutics, Inc. Second Amended and Restated 2016 Employee Stock Purchase Plan; | Compensation | Board | AGAINST | 1 | |
| Banco de Chile SA | March 26, 2026 | Elect Directors | Director Elections | Board | AGAINST | 1 | |
| Bolt Biotherapeutics, Inc. | June 10, 2026 | To elect our two nominees for Class II directors to serve until our 2029 Annual Meeting of Stockholders: William P. Quinn | Director Elections | Board | WITHHOLD | 1 | |
| C4 Therapeutics, Inc. | June 24, 2026 | To approve an amendment to our 2020 Stock Option and Incentive Plan to amend the evergreen provision to include any outstanding pre-funded warrants in the total number of shares of common stock that are issued and outstanding as of each December 31. | Compensation | Board | AGAINST | 1 | |
| C4 Therapeutics, Inc. | June 24, 2026 | To elect three Class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Andrew Hirsch | Director Elections | Board | WITHHOLD | 1 | |
| Cambium Networks Corporation | June 25, 2026 | The election of the two Class III directors and three Class I directors named in the proxy statement: Bruce Felt (Class III) | Director Elections | Board | WITHHOLD | 1 | |
| Cardlytics, Inc. | May 20, 2026 | Election of Directors: Jack Klinck | Director Elections | Board | WITHHOLD | 1 | |
| Cardlytics, Inc. | May 20, 2026 | Election of Directors: Srishti Gupta | Director Elections | Board | WITHHOLD | 1 | |
| Carlsmed, Inc. | June 3, 2026 | To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 annual meeting of stockholders: Niall Casey | Director Elections | Board | WITHHOLD | 1 | |
| Centrais Eletricas Brasileiras SA | April 15, 2026 | Approve Performance Share Plan | Compensation | Board | AGAINST | 1 | |
| Century Therapeutics, Inc. | June 11, 2026 | Election of Class II directors for a three year term expiring in 2029: Alessandro Riva, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Climb Bio, Inc. | June 5, 2026 | The approval of an amendment to our 2021 Equity Incentive Plan to amend the provision providing for an automatic share pool increase to include prefunded warrants in the calculation of the annual increase; and | Compensation | Board | AGAINST | 1 | |
| Companhia de Saneamento Basico do Estado de Sao Paulo SABESP | April 28, 2026 | Approve Restricted Stock Plan (Bonus Estrela) | Compensation | Board | AGAINST | 1 | |
| Companhia de Saneamento Basico do Estado de Sao Paulo SABESP | April 28, 2026 | Elect Eduardo Parente Menezes as Director | Director Elections | Board | AGAINST | 1 | |
| Cue Biopharma, Inc. | April 13, 2026 | The election of seven nominees to our board of directors: Frank Morich | Director Elections | Board | WITHHOLD | 1 | |
| Cue Biopharma, Inc. | April 13, 2026 | The election of seven nominees to our board of directors: Peter A. Kiener | Director Elections | Board | WITHHOLD | 1 | |
| Cue Biopharma, Inc. | June 1, 2026 | The approval of the Cue Biopharma, Inc. 2026 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Curis, Inc. | March 17, 2026 | To approve our 2026 Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| DarioHealth Corp. | July 23, 2025 | To approve an amendment to the Certificate of Incorporation of the Company to increase the number of authorized Common Stock from one hundred sixty million (160,000,000) shares, $0.0001 par value per share, to four hundred million (400,000,000) shares, $0.0001 par value per share; and | Capital Structure | Board | AGAINST | 1 | |
| DarioHealth Corp. | July 23, 2025 | To consider and vote to amend the Company's 2020 Equity Compensation Plan, as amended. | Compensation | Board | AGAINST | 1 | |
| Duluth Holdings Inc. | June 3, 2026 | Election of Directors: Brett L. Paschke | Director Elections | Board | WITHHOLD | 1 | |
| Duluth Holdings Inc. | June 3, 2026 | Election of Directors: David C. Finch | Director Elections | Board | WITHHOLD | 1 | |
| Duluth Holdings Inc. | June 3, 2026 | Election of Directors: Scott K. Williams | Director Elections | Board | WITHHOLD | 1 | |
| Duluth Holdings Inc. | June 3, 2026 | Election of Directors: Stephen L. Schlecht | Director Elections | Board | WITHHOLD | 1 | |
| FORIAN INC. | January 8, 2026 | To approve a redomiciliation of the Company to the State of Maryland through a statutory conversion. | Extraordinary Transactions | Board | AGAINST | 1 | |
| Fathom Holdings Inc. | August 20, 2025 | To approve an amendment to the Fathom Holdings Inc. 2019 Omnibus Stock Incentive Plan to increase the share reserve by one million three hundred thousand (1,300,000) shares of common stock. | Compensation | Board | AGAINST | 1 | |
| Fluent, Inc. | June 17, 2026 | Approve an amendment to the Fluent, Inc. 2022 Omnibus Equity Incentive Plan to increase the number of shares of common stock reserved thereunder to 5,566,666 shares from 3,666,666 shares. | Compensation | Board | AGAINST | 1 | |
| Forte Biosciences, Inc. | May 29, 2026 | The approval of the Company's Amended and Restated 2021 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| GT Biopharma, Inc. | July 24, 2025 | Approval of Amendment No. 1 to the GT Biopharma, Inc. 2022 Omnibus Incentive Plan increasing the number of shares available for future awards thereunder by 583,334 shares of Common Stock. | Compensation | Board | AGAINST | 1 | |
| Gencor Industries, Inc. | September 26, 2025 | Election of Director: General John G. Coburn n et.) | Director Elections | Board | WITHHOLD | 1 | |
| GoPro, Inc. | June 2, 2026 | Approval of Amendment to the GoPro, Inc. 2024 Equity Incentive Plan with additional 13,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| GoPro, Inc. | June 2, 2026 | Election of Directors: Nicholas Woodman | Director Elections | Board | WITHHOLD | 1 | |
| GoPro, Inc. | June 2, 2026 | Election of Directors: Shaz Kahng | Director Elections | Board | WITHHOLD | 1 | |
| GoPro, Inc. | June 2, 2026 | Election of Directors: Susan Lyne | Director Elections | Board | WITHHOLD | 1 | |
| GoPro, Inc. | June 2, 2026 | Election of Directors: Tyrone Ahmad-Taylor | Director Elections | Board | WITHHOLD | 1 | |
| GrowGeneration Corp. | June 18, 2026 | To approve and ratify the amendment and restatement of the Company's Amended and Restated 2018 Equity Incentive Plan, as set forth in Exhibit A attached to the Proxy Statement. | Compensation | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Alejandra Yazmin Soto Ayech as Director of Series B Shareholders | Director Elections | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Angel Losada Moreno as Director of Series B Shareholders | Director Elections | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Board Chair | Director Elections | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Carlos Cardenas Guzman as Director of Series B Shareholders | Director Elections | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Joaquin Vargas Guajardo as Director of Series B Shareholders | Director Elections | Board | AGAINST | 1 | |
| Grupo Aeroportuario del Pacifico SAB de CV | April 22, 2026 | Ratify and/or Elect Juan Diez-Canedo Ruiz as Director of Series B Shareholders | Director Elections | Board | AGAINST | 1 | |
| H World Group Limited | June 26, 2026 | Elect Director Justin Martin Leverenz | Director Elections | Board | AGAINST | 1 | |
| Harvard Bioscience, Inc. | June 2, 2026 | Adoption and approval of an amendment to the Harvard Bioscience, Inc. 2021 Incentive Plan to increase the number of authorized shares of common stock available for issuance by 400,000 shares of common stock. | Compensation | Board | AGAINST | 1 | |
| Ikena Oncology, Inc. | July 15, 2025 | To approve the 2025 Equity Incentive Plan, which will become effective on the date immediately following the consummation of the merger and is contingent on the completion of the merger | Compensation | Board | AGAINST | 1 | |
| ImageneBio, Inc. | June 16, 2026 | To approve an amendment and restatement of the Company's 2025 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the 2025 Plan by 850,000 shares and include in the calculation of the annual automatic share reserve increase shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. | Compensation | Board | AGAINST | 1 | |
| KE Holdings Inc. | June 12, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| KE Holdings Inc. | June 12, 2026 | Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 1 | |
| KE Holdings Inc. | June 12, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| Kalaris Therapeutics, Inc. | August 12, 2025 | The election of two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Srinivas Akkaraju, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Kirkland's, Inc. | July 24, 2025 | To approve an Amendment of the Company's Amended and Restated 2002 Equity Incentive Plan to increase the number of shares available for issuance under that Plan. | Compensation | Board | AGAINST | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Approval of an amendment to the Incentive Plan to increase the number of shares authorized for issuance pursuant to the Incentive Plan and to extend the term of the Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Election of Directors: Grant J. LaMontagne | Director Elections | Board | WITHHOLD | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Election of Directors: Jason Vieth | Director Elections | Board | WITHHOLD | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Election of Directors: Kayla Dean Obia | Director Elections | Board | WITHHOLD | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Election of Directors: Laird Hamilton | Director Elections | Board | WITHHOLD | 1 | |
| Laird Superfood, Inc. | June 25, 2026 | Election of Directors: Michael Cohen | Director Elections | Board | WITHHOLD | 1 | |
| Lazydays Holdings, Inc. | July 3, 2025 | Election of Class A director nominee to serve a three-year term expiring at the 2028 Annual Meeting of Stockholders or until her successor has been duly elected and qualified: Susan Scarola | Director Elections | Board | AGAINST | 1 | |
| LeonaBio, Inc. | March 18, 2026 | To amend our amended and restated certificate of incorporation to increase the number of authorized shares of common stock. | Capital Structure | Board | AGAINST | 1 | |
| LeonaBio, Inc. | March 18, 2026 | To approve the LeonaBio, Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| LeonaBio, Inc. | March 18, 2026 | To approve the issuance of 5,502,402 shares of common stock, par value $0.0001 per share, or the common stock, pursuant to the exercise of a pre-funded warrant, or the Sermonix Pre-Funded Warrant, held by Sermonix Pharmaceuticals, Inc., or Sermonix, in accordance with Nasdaq Rule 5635(a)(2). | Capital Structure | Board | AGAINST | 1 | |
| LeonaBio, Inc. | March 18, 2026 | To approve the issuance of shares of common stock to Perceptive Advisors or its affiliates pursuant to the exercise of warrants if, immediately following such exercise, Perceptive Advisors, together with its affiliates and any other persons whose beneficial ownership of shares of common stock would be aggregated with Perceptive Advisors for purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of our outstanding common stock, in accordance with Nasdaq Rule 5635(b). | Capital Structure | Board | AGAINST | 1 | |
| LeonaBio, Inc. | March 18, 2026 | To approve the issuance of shares of common stock to Sermonix pursuant to an exercise of the Sermonix Pre-Funded Warrant if, immediately following such exercise, Sermonix, together with its affiliates and any other persons whose beneficial ownership of shares of common stock would be aggregated with Sermonix for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, would beneficially own in excess of 19.99% of our outstanding common stock, in accordance with Nasdaq Rule 5635(b). | Capital Structure | Board | AGAINST | 1 | |
| LeonaBio, Inc. | June 22, 2026 | Election of Class III Directors: Kelly A. Romano | Director Elections | Board | WITHHOLD | 1 | |
| Nu Ride, Inc. | December 11, 2025 | Approval of an amendment to the 2020 Equity Incentive Plan to increase the number of shares of Class A common stock reserved thereunder by 1,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| Nu Ride, Inc. | December 11, 2025 | Election of Class I Director: Neil Weiner | Director Elections | Board | WITHHOLD | 1 | |
| Oramed Pharmaceuticals Inc. | August 19, 2025 | To consider and approve an amendment to the Company's Amended and Restated 2019 Stock Incentive Plan: | Compensation | Board | AGAINST | 1 | |
| PAVmed Inc. | March 27, 2026 | Approval of an amendment to the Company's 2014 Long-Term Incentive Equity Plan to increase the total number of shares of the Company's common stock available thereunder by an addition 1,500,000 shares, from 213,517 shares to 1,713,517 shares. | Compensation | Board | AGAINST | 1 | |
| PAVmed Inc. | June 24, 2026 | Approval of amendments to the Company's Employee Stock Purchase Plan (the "ESPP") to (i) increase the total number of shares of the Company's common stock available under the ESPP by an additional 200,000 shares, from 15,774 shares to 215,774 shares, and (ii) raise the annual limit for increases under the evergreen provision from 5,556 shares to 500,000 shares. | Compensation | Board | AGAINST | 1 | |
| PAVmed Inc. | June 24, 2026 | Election of Class A Directors: Ronald M. Sparks | Director Elections | Board | WITHHOLD | 1 | |
| PAVmed Inc. | June 24, 2026 | Election of Class A Directors: Timothy Baxter | Director Elections | Board | WITHHOLD | 1 | |
| PMV Pharmaceuticals, Inc. | June 4, 2026 | Election of Class III Directors: David H. Mack, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| PMV Pharmaceuticals, Inc. | June 4, 2026 | Election of Class III Directors: Laurie Stelzer | Director Elections | Board | WITHHOLD | 1 | |
| PT Telkom Indonesia (Persero) Tbk | September 3, 2025 | Approve Changes in the Boards of the Company | Director Elections | Board | AGAINST | 1 | |
| PT Telkom Indonesia (Persero) Tbk | June 8, 2026 | Approve Changes in the Boards of the Company | Director Elections | Board | AGAINST | 1 | |
| Passage Bio, Inc. | May 19, 2026 | To elect two Class III directors, each to serve a three-year term through the third Annual Meeting of Stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Athena Countouriotis, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| PetMed Express, Inc. | January 21, 2026 | To elect the five nominees listed below to the Board of Directors: James LaCamp | Director Elections | Board | AGAINST | 1 | |
| PetMed Express, Inc. | January 21, 2026 | To elect the five nominees listed below to the Board of Directors: Justin Mennen | Director Elections | Board | AGAINST | 1 | |
| PetMed Express, Inc. | January 21, 2026 | To elect the five nominees listed below to the Board of Directors: Leah A. Solivan | Director Elections | Board | AGAINST | 1 | |
| PetMed Express, Inc. | January 21, 2026 | To elect the five nominees listed below to the Board of Directors: Leslie C.G. Campbell | Director Elections | Board | AGAINST | 1 | |
| PetMed Express, Inc. | January 21, 2026 | To elect the five nominees listed below to the Board of Directors: Peter Batushansky | Director Elections | Board | AGAINST | 1 | |
| Playboy, Inc. | June 16, 2026 | Approve the amendment of the Playboy, Inc. Amended & Restated 2021 Equity and Incentive Compensation Plan (the "Incentive Plan"), to increase the number of shares of Playboy, Inc. common stock available under the Incentive Plan by 10,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| Playboy, Inc. | June 16, 2026 | Election of Directors: James Yaffe | Director Elections | Board | WITHHOLD | 1 | |
| Playboy, Inc. | June 16, 2026 | Election of Directors: Tracey Edmonds | Director Elections | Board | WITHHOLD | 1 | |
| Precision BioSciences, Inc. | May 21, 2026 | Approval of the amendment and restatement of the Company's 2019 Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| Precision BioSciences, Inc. | May 21, 2026 | Election of Class I Directors: Geno Germano | Director Elections | Board | WITHHOLD | 1 | |
| Precision BioSciences, Inc. | May 21, 2026 | Election of Class I Directors: Melinda Brown | Director Elections | Board | WITHHOLD | 1 | |
| Prelude Therapeutics Incorporated | June 9, 2026 | Election of Class III Directors: Paul Scherer, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Pyxis Oncology, Inc. | June 15, 2026 | The election of three Class II directors named in the proxy statement: Freda Lewis-Hall, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Quince Therapeutics, Inc. | June 11, 2026 | To elect one Class I nominee for director to hold office until the 2029 annual meeting of stockholders and until her successor is duly elected and qualified: June Bray | Director Elections | Board | WITHHOLD | 1 | |
| Rafael Holdings, Inc. | January 8, 2026 | Election of Directors: Howard S. Jonas | Director Elections | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 8, 2026 | Election of Directors: Mark N. Stein | Director Elections | Board | AGAINST | 1 |
← Previous Page 25 of 26 Next →
← Back to Guggenheim 2025-2026 overview
Built October 25, 2026 from SEC Form N-PX filings.